Skip to main content
SpringerLink
Log in

Cardiovascular Disease and Acute Coronary Syndrome in the Adult Patient with Congenital Heart Disease

  • Chapter
  • First Online:
Intensive Care of the Adult with Congenital Heart Disease

Part of the book series: Congenital Heart Disease in Adolescents and Adults ((CHDAA))

  • 875 Accesses

Abstract

The number of patients with congenital heart disease (CHD) reaching adulthood has risen dramatically over time. With over 90% of the CHD population surviving, there are now more adults with CHD than children. As this population ages, they face both the inherent risks associated with their underlying cardiac lesions and the increasing possibility of acquired cardiovascular disease. This chapter reviews the global burden of cardiovascular disease and discusses cardiovascular risk assessment as it pertains to the adult congenital heart disease population and the presentation and management of acute coronary syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update. Circulation. 2017;135:e1–458.

    Article  Google Scholar 

  2. Pillutla P, Shetty KD, Foster E. Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am Heart J. 2009;158(5):874–9.

    Article  PubMed  Google Scholar 

  3. Giannakoulas G, Dimopoulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vatankulu MA, et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103(10):1445–50.

    Article  PubMed  Google Scholar 

  4. Lui GK, Fernandes S, McElhinney DB. Management of cardiovascular risk factors in adults with congenital heart disease. J Am Heart Assoc. 2014;3(6):e001076.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tutarel O, Kempny A, Alonso-Gonzalez R, Jabbour R, Li W, Uebing A, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35(11):725–32.

    Article  PubMed  Google Scholar 

  6. Tutarel O. Acquired heart conditions in adults with congenital heart disease: a growing problem. Heart. 2014;100:1317–21.

    Article  PubMed  Google Scholar 

  7. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50.

    Article  CAS  PubMed  Google Scholar 

  8. Moons P, Deyk KV, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13(4):612–6.

    Article  PubMed  Google Scholar 

  9. Bhatt AB, Foster E, Kuehl K, Alpert J, Brabeck S, Crumb S, Davidson WR, Earing MG, Ghoshhajra BB, Karamlou T, Mital S, Ting J, Tseng ZH. Congenital heart disease in the older adult: A scientific statement from the American Heart Association. Circulation. 2015;131(21):1884–931.

    Article  PubMed  Google Scholar 

  10. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, Sean C, D’Agostino RB Sr, et al. ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935–59.

    Article  PubMed  Google Scholar 

  11. World Health Organization. A global brief on hypertension. Geneva; 2013. p. 1–40. Report No.: WHO/DCO/WHD/2013.2.

    Google Scholar 

  12. Ridker PM, Libby P, Buring JE, Ridker PM, Libby P, Buring JE. Risk markers and the primary prevention of cardiovascular disease. In: Braunwald’s heart disease a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier; 2015. p. 891–933.

    Google Scholar 

  13. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, SM DP, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127–248.

    Article  PubMed  Google Scholar 

  14. Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta. Circulation. 1989;80:840–5.

    Article  CAS  PubMed  Google Scholar 

  15. Canniffe C, Ou P, Walsh K, Bonnet D, Celermajer D. Hypertension after repair of aortic coarctation—a systematic review. Int J Cardiol. 2013;167(6):2456–61.

    Article  PubMed  Google Scholar 

  16. Bocelli A, Favilli S, Pollini I, Bini RM, Ballo P, Chiappa E, et al. Prevalence and long-term predictors of left ventricular hypertrophy, late hypertension, and hypertensive response to exercise after successful aortic coarctation repair. Pediatr Cardiol. 2012;34(3):620–9.

    Article  PubMed  Google Scholar 

  17. Quennelle S, Powell AJ, Geva T, Prakash A. Persistent aortic arch hypoplasia after coarctation treatment is associated with late systemic hypertension. J Am Heart Assoc. 2015;4(7):e001978.

    Article  PubMed  PubMed Central  Google Scholar 

  18. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(5):3143–421.

    Google Scholar 

  19. Cholesterol Treatment Trialists’ CTT Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials. Lancet. 2010;376:1670–81.

    Article  PubMed Central  Google Scholar 

  20. Cholesterol Treatment Trialists’ CTT Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–90.

    Article  PubMed Central  Google Scholar 

  21. Zomer AC, Vaartjes I, Uiterwaal CSP, van der Velde ET, Sieswerda GJT, Wajon EMC, et al. Social burden and lifestyle in adults with congenital heart disease. Am J Cardiol. 2012;109(11):1657–63.

    Article  PubMed  Google Scholar 

  22. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zaidi AN, Bauer JA, Michalsky MP, Olshove V, Boettner B, Phillips A, Cook SC. The impact of obesity on early postoperative outcomes in adults with congenital heart disease. Congenit Heart Dis. 2011;6(3):241–6.

    Article  PubMed  Google Scholar 

  24. World Health Organization. Global report on diabetes. Geneva; 2016. p. 1–88.

    Google Scholar 

  25. Wang P, Huang R, Lu S, Xia W, Sun H, Sun J, et al. HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis. Cardiovasc Diabetol. 2015;14(124):1–15.

    Google Scholar 

  26. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011;343:d4169.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus (Review). Cochrane Database Syst Rev. 2013;11:CD008143.

    Google Scholar 

  28. Savji N, Rockman CB, Skolnick AH, Guo Y, Adelman MA, Riles T, et al. Association between advanced age and vascular disease in different arterial territories. A population database of over 3.6 million subjects. J Am Coll Cardiol. 2013;61(16):1736–43.

    Article  PubMed  Google Scholar 

  29. Lloyd-Jones DM, Nam B-H, D’Agostino RB Sr, Levy D, Murabito JM, Wang TJ, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 2004;3291:2204–11.

    Article  Google Scholar 

  30. Miyamoto K, Takeuchi D, Inai K, Shinohara T, Nakanishi T. Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles. Heart Vessel. 2016;31:1834–47.

    Article  Google Scholar 

  31. Tomita H, Takamuro M, Soda W, Hatakeyama K, Tsutsumi H. Increased serum high-sensitivity C-reactive protein is related to hypoxia and brain natriuretic peptide in congenital heart disease. Pediatr Int. 2008;50:436–40.

    Article  CAS  PubMed  Google Scholar 

  32. Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Généreux P. Coronary artery calcification. Pathogenesis and prognostic implications. J Am Coll Cardiol. 2014;63(17):1703–14.

    Article  CAS  PubMed  Google Scholar 

  33. Halpern DG, Steigner ML, Prabhu SP, Valente AM, Sanders SP. Cardiac calcifications in adults with congenital heart defects. Congenit Heart Dis. 2015;10:396–402.

    Article  PubMed  Google Scholar 

  34. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham heart study. Circulation. 2004;110:522–7.

    Article  PubMed  Google Scholar 

  35. Sidney S, Quesenberry CP Jr, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol. 2016;1(5):594–9.

    Article  PubMed  Google Scholar 

  36. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2011;57(19):e215–367.

    Article  PubMed  Google Scholar 

  37. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2013;61(4):e78–e140.

    Article  PubMed  Google Scholar 

  38. Mega JL, Morrow DA. ST-elevation myocardial infarction: management. In: Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier; 2015. p. 1095–154.

    Google Scholar 

  39. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50(7):e1–e157.

    Article  PubMed  Google Scholar 

  40. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, Part I. Mayo Clin Proc. 2009;84(10):917–38.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Srikanth S, Ambrose JA. Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI. Curr Cardiol Rev. 2012;8:168–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Mirvis DM, Goldberger AL. Electrocardiography. In: Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier; 2015. p. 114–54.

    Google Scholar 

  43. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, ESC/ACCF/AHA/WHF Expert Consensus Document. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35.

    Article  PubMed  Google Scholar 

  44. Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. N Engl J Med. 1996;334(8):481–7.

    Article  CAS  PubMed  Google Scholar 

  45. Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med. 2012;60(6):766–76.

    Article  PubMed  Google Scholar 

  46. Meyers HP, Limkakeng AT Jr, Jaffa EJ, Patel A, Theiling BJ, Rezaie SR, et al. Validation of the modified Sgarbossa criteria for acute coronary occlusion in the setting of left bundle branch block: a retrospective case-control study. Am Heart J. 2015;170:1255–64.

    Article  PubMed  Google Scholar 

  47. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.

    Article  PubMed  Google Scholar 

  48. Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol. 2006;47:312–8.

    Article  CAS  PubMed  Google Scholar 

  49. Giugliano RP, Cannon CP, Braunwald E, Giugliano RP, Braunwald E. Non-ST elevation acute coronary syndromes. In: Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier; 2015. p. 27.

    Google Scholar 

  50. Patti G, Cannon CP, Murphy SA, Mega S, Pasceri V, Briguori C, et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation. 2011;123:1622–32.

    Article  CAS  PubMed  Google Scholar 

  51. Scirica BM, Morrow DA. ST-elevation myocardial infarction: pathology, pathophysiology, and clinical features. In: Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier; 2015. p. 27.

    Google Scholar 

  52. Keeley EC, Hillis LD. Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med. 2007;356:47–54.

    Article  CAS  PubMed  Google Scholar 

  53. Pinto DS, Frederick PD, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011;124:2512–21.

    Article  PubMed  Google Scholar 

  54. Terkelsen CJ, Sorensen JT, Maeng M, Jensen LO, Tilsted H-H, Trautner S, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304(7):763–71.

    Article  CAS  PubMed  Google Scholar 

  55. Mauri L, Bhatt DL, Mauri L, Bhatt DL. Percutaneous coronary intervention. In: Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier; 2015. p. 24.

    Google Scholar 

  56. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with Coronary Artery Disease. J Am Coll Cardiol. 2016;68(10):1082–115.

    Article  PubMed  Google Scholar 

  57. Braunwald E. Unstable angina and non-ST elevation myocardial infarction. Am J Respir Crit Care Med. 2012;185(9):924–32.

    Article  CAS  PubMed  Google Scholar 

  58. Damman P, Woudstra P, Kuijt WJ, de Winter RJ, James SK. P2Y12 platelet inhibition in clinical practice. J Thromb Thrombolysis. 2011;33:143–53.

    Article  PubMed Central  Google Scholar 

  59. White HD, Chew DP. Acute myocardial infarction. Lancet. 2008;372:570–84.

    Article  CAS  PubMed  Google Scholar 

  60. Fibrinolytic Therapy Trialists’ FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–22.

    Google Scholar 

  61. Van de Werf F. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet. 1999;354(9180):716–22.

    Article  Google Scholar 

  62. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014;129(23):2388–94.

    Article  PubMed  Google Scholar 

  63. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease. JAMA Intern Med. 2014;174(2):223–30.

    Article  PubMed  Google Scholar 

  64. Kutty RS, Jones N, Moorjani N. Mechanical complications of acute myocardial infarction. Cardiol Clin. 2013;31:519–31.

    Article  PubMed  Google Scholar 

  65. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–65.

    Article  CAS  PubMed  Google Scholar 

  66. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56(4):254–63.

    Article  PubMed  Google Scholar 

  67. Vora AN, Wang TY, Hellkamp AS, Thomas L, Henry TD, Goyal A, et al. Differences in short- and long-term outcomes among older patients with ST-elevation verses non-ST-elevation myocardial infarction with angiographically proven coronary artery disease. Circ Cardiovasc Qual Outcomes. 2016;9:513–22.

    Article  PubMed  Google Scholar 

  68. Fox KAA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JGP, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2010;55(22):2435–45.

    Article  PubMed  Google Scholar 

  69. Anderson ML, Peterson ED, Peng SA, Wang TY, Ohman EM, Bhatt DL, et al. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification. Circ Cardiovasc Qual Outcomes. 2013;6:708–15.

    Article  PubMed  Google Scholar 

  70. Tanaka A, Shimada K, Sano T, Namba M, Sakamoto T, Nishida Y, et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol. 2005;45(10):1594–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, USA

    Jordan D. Awerbach, Wayne J. Franklin & Peter R. Ermis

  2. Section of Critical Care Medicine and Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, USA

    Ronald A. Bronicki

Authors
  1. Jordan D. Awerbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne J. Franklin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald A. Bronicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter R. Ermis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Children’s Hospital Colorado, University of Colorado Denver, Aurora, CO, USA

    Eduardo da Cruz

  2. Pediatric Intensive Care, Royal Brompton & Harefield NHS Foundation Trust, London, UK

    Duncan Macrae

  3. Adult Congenital Heart Program, Heart Institute, Cincinnati Children Hospital Medical Center, Cincinnati, OH, USA

    Gary Webb

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Awerbach, J.D., Franklin, W.J., Bronicki, R.A., Ermis, P.R. (2019). Cardiovascular Disease and Acute Coronary Syndrome in the Adult Patient with Congenital Heart Disease. In: da Cruz, E., Macrae, D., Webb, G. (eds) Intensive Care of the Adult with Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-94171-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94171-4_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94170-7

  • Online ISBN: 978-3-319-94171-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation